Close Asset Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Close Asset Management's NVAX Position: Q3 2026 in Review
Close Asset Management held its Novavax (NVAX) position steady in Q3 2026 at 50 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #249.
Close Asset Management first reported a position in NVAX in Q2 2022 and has held it in 14 quarters since. The position peaked at $482K in Q2 2022. 262 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- Close Asset Management held 50 shares of Novavax worth $1K as of Q3 2026.
- Close Asset Management left its Novavax share count unchanged in Q3 2026.
- Novavax made up ﹤0.01% of Close Asset Management's portfolio in Q3 2026, its #249 holding.
- Close Asset Management first reported a position in Novavax in Q2 2022 and has held it in 14 quarters since.
- Close Asset Management's Novavax position peaked at $482K in Q2 2022.
- 262 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on Close Asset Management's 13F filing for Q3 2026, filed 30 Oct 2026.